BCL2A1 and melanoma: So far, there are no publications describing BH3 mimetic drugs targeting the pro-survival protein BFL-1, whose gene is frequently amplified and whose mRNA is highly expressed in melanoma [7–9], We revealed by western blot analysis that BFL-1 protein can be readily detected in >50% of human melanoma-derived cell lines.